The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...

(Reuters) -The U.S. House Judiciary Committee on Monday subpoenaed a former Pfizer executive after he declined to voluntarily ...

BRUSSELS (AP) — The president of the European Union’s executive branch, Ursula von der Leyen, faces a no-confidence vote this ...

At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...

Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...

A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among ...

PFE's robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.

The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the ...

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.

House Judiciary Chair Jim Jordan subpoenaed Dr. Philip Dormitzer after he refused to testify in the 2020 vaccine delay probe, ...